Centogene N.V.

Centogene N.V. provides pharmaceutical solutions and diagnostic tests across Europe, the Middle East, North America, Latin America, and the Asia Pacific. It offers data-driven answers for rare and neurodegenerative diseases to patients, physicians, and pharmaceutical companies. Its products include CENTOGENE MOx 2.0, CentoCloud, FilterTool, and NEW CentoGenome, along with services such as target and drug screening, clinical development, market access, and CENTOGENE Biodatabank licenses. Founded in 2006, the company is headquartered in Rostock, Germany.